Search results
J&J’s DePuy Synthes orthopedics robot cleared for partial knee replacements
FierceBiotech· 3 days agoJohnson & Johnson MedTech’s orthopedics division, DePuy Synthes, has claimed an FDA clearance for...
Jannik Sinner dispels an important taboo
Tennis World· 22 hours agoThe 22-year-old Italian has been able to resist in times of difficulty, canceling three dangerous break balls in the partial second and showing off plays...
‘Federer: Twelve Final Days’ Review: A Partial Backstage Pass to the Tennis Great’s Retirement Party
Variety· 2 days agoIn his classic 1994 essay “How Tracy Austin Broke My Heart,” David Foster Wallace pondered why so...
Zentalis Pharmaceutical Studies on Partial Clinical Hold Following Deaths
Market Watch· 2 days agoPublished: June 18, 2024 at 7:31 a.m. ETShareResizeBy Adriano MarcheseAbout Dow Jones NewswiresDow Jones Newswires is a market-moving financial and business news source, used by wealth managers ...
Boris Johnson announces release date for ‘unrestrained’ memoir
Daily Telegraph· 9 hours agoMr Johnson’s publisher said Unleashed was an “honest, unrestrained and deeply revealing book by the...
Catherine making 'good progress' in cancer treatment as she announces partial public return
Los Angeles Times· 6 days agoCatherine, Princess of Wales, has issued the first substantial update about her health since...
Treatment model in France shows better access to methadone in US could save lives
Medical Xpress· 50 minutes agoA new study published in the International Journal of Drug Policy highlights differences between the...
US FDA puts partial clinical hold on Zentalis’ cancer drug studies; shares drop
WSAU Wausau· 2 days ago(Reuters) - Zentalis Pharmaceuticals said on Tuesday the U.S. Food and Drug Administration has...
‘Federer: Twelve Final Days’ Review: A Partial Backstage Pass to the Tennis Great’s Retirement Party
Variety via Yahoo News· 2 days agoIn his classic 1994 essay “How Tracy Austin Broke My Heart,” David Foster Wallace pondered why so...
US FDA puts Zentalis' cancer drug studies on partial hold after patient deaths
Reuters via Yahoo News· 2 days agoShares of the drug developer slumped about 26% to $6.22 in early trading. The drug candidate,...